The ClariSigmam is an innovative breast cancer prediction marker. It is a breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms. Quantitative breast density is the main indicator in breast cancer screening and diagnosis. The powerful pre-trained deep learning model ensures to make consistent clinical decision marking in an objective and convenient way. Novel Deep Learning Technology provides a fully automated quantification for breast and mammary area and proportion density measurements. With the world’s highest accuracy rate, ClariSigmam is convenient with a smart workflow at an affordable cost.
South KoreaUSA